Antares Pharma Announces Update to QuickShot Testosterone Program

[Business Wire] – Antares Pharma, Inc. today announced that a meeting was held with the U.S. Food and Drug Administration to discuss a registration study for the VIBEX QuickShot auto injector in testosterone deficient adult males. more

View todays social media effects on ATRS

View the latest stocks trending across Twitter. Click to view dashboard

See who Antares is hiring next, click here to view